Open Access
Open access
Clinical Infectious Diseases, volume 50, issue s1, pages S10-S15

Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD

Eisenstein Barry I. 1
Oleson Jr Frederick B 1
Baltz Richard H. 1
1
 
Cubist Pharmaceuticals Lexington Massachusetts
Publication typeJournal Article
Publication date2010-01-12
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor11.8
ISSN10584838, 15376591
Microbiology (medical)
Infectious Diseases
Abstract
Daptomycin has been approved and successfully launched for the treatment of complicated skin and skin-structure infections caused by gram-positive pathogens [1] and bacteremia and right-sided endocarditis due to Staphylococcus aureus, including strains that are resistant to methicillin or other antibiotics [2]. The development of the drug, however, was not straightforward; it involved a cast of characters, including scientists at Eli Lilly and at Cubist Pharmaceuticals. Of most importance, the development of daptomycin involved the tenacious leadership of Dr. Francis Tally. As a tribute to Dr. Tally, we attempt to reconstruct the path of daptomycin from the mountain to the clinic.

Citations by journals

1
2
3
4
5
6
7
Journal of Industrial Microbiology and Biotechnology
Journal of Industrial Microbiology and Biotechnology, 7, 6.19%
Journal of Industrial Microbiology and Biotechnology
7 publications, 6.19%
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 5, 4.42%
Antimicrobial Agents and Chemotherapy
5 publications, 4.42%
Antibiotics
Antibiotics, 4, 3.54%
Antibiotics
4 publications, 3.54%
Applied Microbiology and Biotechnology
Applied Microbiology and Biotechnology, 3, 2.65%
Applied Microbiology and Biotechnology
3 publications, 2.65%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 3, 2.65%
International Journal of Antimicrobial Agents
3 publications, 2.65%
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 3, 2.65%
Journal of Antimicrobial Chemotherapy
3 publications, 2.65%
Angewandte Chemie - International Edition
Angewandte Chemie - International Edition, 2, 1.77%
Angewandte Chemie - International Edition
2 publications, 1.77%
Pathogens
Pathogens, 2, 1.77%
Pathogens
2 publications, 1.77%
Pharmaceuticals
Pharmaceuticals, 2, 1.77%
Pharmaceuticals
2 publications, 1.77%
Current Infectious Disease Reports
Current Infectious Disease Reports, 2, 1.77%
Current Infectious Disease Reports
2 publications, 1.77%
Journal of Antibiotics
Journal of Antibiotics, 2, 1.77%
Journal of Antibiotics
2 publications, 1.77%
BMC Infectious Diseases
BMC Infectious Diseases, 2, 1.77%
BMC Infectious Diseases
2 publications, 1.77%
Journal of Biological Chemistry
Journal of Biological Chemistry, 2, 1.77%
Journal of Biological Chemistry
2 publications, 1.77%
Biochimica et Biophysica Acta - Biomembranes
Biochimica et Biophysica Acta - Biomembranes, 2, 1.77%
Biochimica et Biophysica Acta - Biomembranes
2 publications, 1.77%
Journal of Clinical Pharmacology
Journal of Clinical Pharmacology, 2, 1.77%
Journal of Clinical Pharmacology
2 publications, 1.77%
Angewandte Chemie
Angewandte Chemie, 2, 1.77%
Angewandte Chemie
2 publications, 1.77%
Journal of Physical Chemistry B
Journal of Physical Chemistry B, 2, 1.77%
Journal of Physical Chemistry B
2 publications, 1.77%
Organic and Biomolecular Chemistry
Organic and Biomolecular Chemistry, 2, 1.77%
Organic and Biomolecular Chemistry
2 publications, 1.77%
Molecular Diversity
Molecular Diversity, 1, 0.88%
Molecular Diversity
1 publication, 0.88%
Australian Journal of Chemistry
Australian Journal of Chemistry, 1, 0.88%
Australian Journal of Chemistry
1 publication, 0.88%
Canadian Journal of Microbiology
Canadian Journal of Microbiology, 1, 0.88%
Canadian Journal of Microbiology
1 publication, 0.88%
Microbiology
Microbiology, 1, 0.88%
Microbiology
1 publication, 0.88%
Current Opinion in Infectious Diseases
Current Opinion in Infectious Diseases, 1, 0.88%
Current Opinion in Infectious Diseases
1 publication, 0.88%
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 1, 0.88%
Therapeutic Drug Monitoring
1 publication, 0.88%
European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, 1, 0.88%
European Journal of Gastroenterology and Hepatology
1 publication, 0.88%
Journal of Orthopaedic Trauma
Journal of Orthopaedic Trauma, 1, 0.88%
Journal of Orthopaedic Trauma
1 publication, 0.88%
Clinical journal of the American Society of Nephrology : CJASN
Clinical journal of the American Society of Nephrology : CJASN, 1, 0.88%
Clinical journal of the American Society of Nephrology : CJASN
1 publication, 0.88%
World Journal of Hepatology
World Journal of Hepatology, 1, 0.88%
World Journal of Hepatology
1 publication, 0.88%
World Journal of Gastroenterology
World Journal of Gastroenterology, 1, 0.88%
World Journal of Gastroenterology
1 publication, 0.88%
1
2
3
4
5
6
7

Citations by publishers

5
10
15
20
25
Springer Nature
Springer Nature, 25, 22.12%
Springer Nature
25 publications, 22.12%
Elsevier
Elsevier, 16, 14.16%
Elsevier
16 publications, 14.16%
Wiley
Wiley, 9, 7.96%
Wiley
9 publications, 7.96%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 7.96%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 7.96%
American Society for Microbiology
American Society for Microbiology, 7, 6.19%
American Society for Microbiology
7 publications, 6.19%
American Chemical Society (ACS)
American Chemical Society (ACS), 6, 5.31%
American Chemical Society (ACS)
6 publications, 5.31%
Wolters Kluwer Health
Wolters Kluwer Health, 5, 4.42%
Wolters Kluwer Health
5 publications, 4.42%
Oxford University Press
Oxford University Press, 4, 3.54%
Oxford University Press
4 publications, 3.54%
Baishideng Publishing Group
Baishideng Publishing Group, 2, 1.77%
Baishideng Publishing Group
2 publications, 1.77%
Frontiers Media S.A.
Frontiers Media S.A., 2, 1.77%
Frontiers Media S.A.
2 publications, 1.77%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 2, 1.77%
American Society for Biochemistry and Molecular Biology
2 publications, 1.77%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 1.77%
Royal Society of Chemistry (RSC)
2 publications, 1.77%
Taylor & Francis
Taylor & Francis, 2, 1.77%
Taylor & Francis
2 publications, 1.77%
CSIRO Publishing
CSIRO Publishing, 1, 0.88%
CSIRO Publishing
1 publication, 0.88%
Canadian Science Publishing
Canadian Science Publishing, 1, 0.88%
Canadian Science Publishing
1 publication, 0.88%
Microbiology Society
Microbiology Society, 1, 0.88%
Microbiology Society
1 publication, 0.88%
American Society of Nephrology
American Society of Nephrology, 1, 0.88%
American Society of Nephrology
1 publication, 0.88%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.88%
Public Library of Science (PLoS)
1 publication, 0.88%
AOAC International
AOAC International, 1, 0.88%
AOAC International
1 publication, 0.88%
American Association for Clinical Chemistry
American Association for Clinical Chemistry, 1, 0.88%
American Association for Clinical Chemistry
1 publication, 0.88%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 0.88%
Cold Spring Harbor Laboratory
1 publication, 0.88%
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy, 1, 0.88%
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
1 publication, 0.88%
5
10
15
20
25
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Eisenstein B. I., Oleson Jr F. B., Baltz R. H. Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD // Clinical Infectious Diseases. 2010. Vol. 50. No. s1. p. S10-S15.
GOST all authors (up to 50) Copy
Eisenstein B. I., Oleson Jr F. B., Baltz R. H. Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD // Clinical Infectious Diseases. 2010. Vol. 50. No. s1. p. S10-S15.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1086/647938
UR - https://doi.org/10.1086%2F647938
TI - Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
T2 - Clinical Infectious Diseases
AU - Eisenstein, Barry I.
AU - Oleson Jr, Frederick B
AU - Baltz, Richard H.
PY - 2010
DA - 2010/01/12 00:00:00
PB - Oxford University Press
SP - S10-S15
IS - s1
VL - 50
SN - 1058-4838
SN - 1537-6591
ER -
BibTex |
Cite this
BibTex Copy
@article{2010_Eisenstein
author = {Barry I. Eisenstein and Frederick B Oleson Jr and Richard H. Baltz},
title = {Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD},
journal = {Clinical Infectious Diseases},
year = {2010},
volume = {50},
publisher = {Oxford University Press},
month = {jan},
url = {https://doi.org/10.1086%2F647938},
number = {s1},
pages = {S10--S15},
doi = {10.1086/647938}
}
MLA
Cite this
MLA Copy
Eisenstein, Barry I., et al. “Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD.” Clinical Infectious Diseases, vol. 50, no. s1, Jan. 2010, pp. S10-S15. https://doi.org/10.1086%2F647938.
Found error?